Fampridine sustained release - Acorda Therapeutics
At a glance
- Drug Originator Elan Drug Technologies
- Drug Licenced by Biogen; UCB
- Drug Class Aminopyridines; Neuroprotectants; Small molecules
- Mechanism of Action Potassium channel antagonists
- USA Patent Applicants MERZ PHARMS
- USA Patents 7
- NDAs 1
- Patent Applications 2,942
Table of Contents
Disclaimer